Aileron Therapeutics, Inc.
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell…
Biotechnology
US, Boston [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Aileron Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Aileron Therapeutics, Inc. has no acquisition track records yet.